EXHIBIT 10.1 COMPENSATION OF NAMED EXECUTIVE OFFICERS
EX-10.1 2 dex101.htm COMPENSATION OF NAMED EXECUTIVE OFFICERS Compensation of Named Executive Officers
EXHIBIT 10.1
COMPENSATION OF NAMED EXECUTIVE OFFICERS
| Name and Position | Fiscal 2006 Base Salary ($) | Fiscal 2007 Base Salary ($) | Fiscal 2006 Bonus ($) | |||
| Peter D. Meldrum President and Chief Executive Officer | 615,000 | 676,500 | 338,250 | |||
| Gregory C. Critchfield, M.D. President, Myriad Genetic Laboratories, Inc. | 424,000 | 465,000 | 200,000 | |||
| Adrian N. Hobden, Ph.D. President, Myriad Pharmaceuticals, Inc. | 424,000 | 465,000 | 200,000 | |||
| Jay M. Moyes Chief Financial Officer | 326,500 | 355,000 | 160,000 | |||
| Mark H. Skolnick, Ph.D. (1) Chief Scientific Officer | 445,000 | 480,600 | 130,000 |
| (1) | Dr. Skolnick is compensated on an hourly basis. Base salary information reflects an annualized salary based on 2080 hours worked in a fiscal year. Actual amounts paid to Dr. Skolnick may vary significantly depending on the actual number of hours worked. |
